Comparison of Spinoglenoid and Suprascapular Notch Approaches and Neuromodulation of the Suprascapular Nerve Under Ultrasonography Guided in Shoulder Pain

NCT06852781 | Completed

• 1 other identifier: neuromodulation,shoulder pain
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

Shoulder pain is a musculoskeletal system (MSS) disease that is frequently seen in adults and tends to become chronic. It ranks 3rd among MSS diseases after low back and knee pain. The main causes of shoulder pain are compression syndromes, acromioclavicular (AC) and glenohumeral joint degeneration, adhesive capsulitis, and biceps tendinopathy. Pathology may be in the joint, bone, muscle, tendon ligament, or bursa. Pain restricts the passive and active range of motion of the shoulder joint, impairing the quality of daily life and activity. It is thought to be between 20% and 50% in the adult population in a 1-year period, and its lifetime prevalence is approximately 10%. Central sensitization develops in cases where the pain is progressive and becomes chronic over time. It has been observed that it becomes chronic in more than 40% of patients in a 1-year period. Thus, shoulder pain becomes a biopsychosocial disease over time. Physical therapy, medical, interventional methods, and surgery are applied in the treatment of shoulder pain. In physical therapy, exercises and some physical medicine modalities are applied to increase joint range of motion and reduce pain, while in medical treatment, oral analgesics, myorelaxants, and topical analgesics are used. Interventional intra-articular steroid injections and distal suprascapular nerve (SS) blockade radiofrequency applications are among the effective treatment options.

Conditions

Shoulder Pain Chronic; Neuromodulation; Ultrasound Guided

Outcome Measures

Primary Outcomes (1)

• Activity visual analogue scale (VAS)

  one year

Study Arms (1)

Comparison of Spinoglenoid and Suprascapular Notch Approaches and Neuromodulation of the Suprascapul

Comparison of Spinoglenoid and Suprascapular Notch Approaches and Neuromodulation of the Suprascapular Nerve under Ultrasonography Guided in Shoulder Pain

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

\- Patients over the age of 18 who have pain at or above visual analog scale (VAS) 4 despite pharmacological agents and physical therapy (passive range of motion, strengthening exercises) for more than 3 months and who meet the inclusion criteria will be included in the study.

You may qualify if:

• Patients with complete data to be scanned in their files

You may not qualify if:

• Patients with known malignancy,
• patients who had shoulder injections within the last 3 months,
• patients who changed their medical analgesic treatment or underwent surgery during follow-up,
• patients with previous shoulder surgery or deformity,
• patients with inflammatory arthritis and fibromyalgia,
• patients with known cervical disc herniation,
• patients with pacemakers, pregnant women,
• patients with chronic decompensated disease,
• hemiplegic patients,
• patients with major psychopathology,
• patients allergic to medications used during the procedure,
• patients with infection in the procedure area,
• patients with bleeding disorders, and patients who did not agree to participate in the study were excluded from the study.

Sponsors & Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital: lead

Study Sites (1)

Kanuni Sultan Süleyman Training and Research Hospital

Istanbul, Turkey, 34000, Turkey (Türkiye)

Location

Study Officials

• altun

  Kanuni Sultan Süleyman Training and Research Hospital

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: pain specialist

Study Record Dates

• First Submitted: February 22, 2025
• First Posted: February 28, 2025
• Study Start: January 1, 2025
• Primary Completion: May 1, 2025
• Study Completion: June 1, 2025
• Last Updated: September 19, 2025

Record last verified: 2025-09

Locations

TU (1)